X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Tuberculosis

期刊標題檢索 TUBERCULOSIS 最新評論: Review speed: 6.0 | Submission hit rate: 50.0 Emphasized research di... (2024-05-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Tuberculosis]您好,您是該頁面的第 27004 位訪客。

期刊簡介
期刊名稱Tuberculosis Tuberculosis
LetPub Score
6.0
50 ratings
Rate

Reputation
7.2

Influence
4.8

Speed
6.7

期刊簡稱TUBERCULOSIS
ISSN1472-9792
E-ISSN1873-281X
h-index79
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.6050.783
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Infectious Diseases
Q2153 / 344
Category: Medicine
Subcategory: Microbiology (medical)
Q371 / 140
Category: Medicine
Subcategory: Microbiology
Q3110 / 182
Category: Medicine
Subcategory: Immunology
Q3149 / 236

自引率 (2023-2024)7.10%自引率趨勢
掲載範囲
Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis, notably on bacteriological, immunological and pathogenesis aspects of the disease. The journal publishes original research and reviews on the host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism, however discourages submissions with a meta-analytical focus (for example, articles based on searches of published articles in public electronic databases, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). We do not publish Clinical Case-Studies.

Areas on which submissions are welcomed include:

-Clinical TrialsDiagnostics-
Antimicrobial resistance-
Immunology-
Leprosy-
Microbiology, including microbial physiology-
Molecular epidemiology-
Non-tuberculous Mycobacteria-
Pathogenesis-
Pathology-
Vaccine development.

This Journal does not accept case-reports.

The resurgence of interest in tuberculosis has accelerated the pace of relevant research and Tuberculosis has grown with it, as the only journal dedicated to experimental biomedical research in tuberculosis.
官方網站http://journalinsights.elsevier.com/journals/1472-9792
在線稿件提交https://www.editorialmanager.com/TUBE
開放訪問No
出版商Churchill Livingstone
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年2001
每年文章數96每年文章數趨勢
黃金OA百分比26.97%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ3118/181
MICROBIOLOGYSCIEQ385/161
RESPIRATORY SYSTEMSCIEQ240/100
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-9792%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【Tuberculosis】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Thoracic OncologyH-index: 113

    CiteScore: 36.00
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEH-index: 343

    CiteScore: 27.30
    EUROPEAN RESPIRATORY JOURNALH-index: 216

    CiteScore: 27.50
    CHESTH-index: 267

    CiteScore: 13.70
    THORAXH-index: 200

    CiteScore: 16.10
    RESPIROLOGYH-index: 72

    CiteScore: 10.60
    JOURNAL OF HEART AND LUNG TRANSPLANTATIONH-index: 122

    CiteScore: 10.10
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGYH-index: 147

    CiteScore: 11.20
    Journal of Cystic FibrosisH-index: 65

    CiteScore: 10.10
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERYH-index: 180

    CiteScore: 11.20
    學科內最受檢索的期刊 頁面查看次數
    LUNG CANCER79523
    CHEST70504
    Journal of Thoracic Oncology58097
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE52732
    EUROPEAN RESPIRATORY JOURNAL50456
    RESPIROLOGY45378
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY43473
    ANNALS OF THORACIC SURGERY43326
    THORAX42037
    RESPIRATORY RESEARCH41433
  •  

    Tuberculosis Tuberculosis
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Tuberculosis] 的評論撰寫評論
作者: 天神院梦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-04 14:15:43 評論於
Review speed: 6.0 | Submission hit rate: 50.0 Emphasized research direction: Brain tuberculosis; Immunity; Pathology Experience sharing: Tuberculosis is a relatively niche professional journal, and the control of paper quality is still relatively strict. Among the journals with scores of 3-5, the review process and requirements are relatively strict. Due to the limited number of annual publications (55 papers), it is difficult to publish there. Papers with scores of 3 need to be solid and with a workload comparable to papers with scores of 3-5. Looking through previous articles, there are often valuable articles with a lot of work involved
(0) 讚! | 天神院梦凝

作者: 地狱回来的人


領域: 医学
審稿時間: 8.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-30 09:30:16 評論於
It is a long-established publication, which used to be quite prestigious. However, in recent years, its impact factor has been hovering around 3, which is a self-inflicted wound. The editor-in-chief is British, unfriendly to researchers from developing countries, and very arrogant. The Chinese editors in the editorial office basically have no authority to handle submissions, and senior editors like Sabine have left around 2018, making the review process now chaotic and with very low timeliness
(3) 讚! | 地狱回来的人

作者: 尔曹身与名俱灭


領域: 医学
審稿時間: 10.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-29 14:04:26 評論於
Conducting drug-resistant tuberculosis surveillance took four months for the first round of review, with two reviewers assigned every two weeks until two and a half months later, when two reviewers finally accepted the review. After accepting the review, there was no progress for a month. After three reminders, the editor-in-chief became very impatient and was about to withdraw the submission when the manuscript was finally reviewed. After minor revisions, the manuscript was quickly resubmitted, but it took almost a month for the editor to respond, claiming to be on vacation. After the vacation, the manuscript was sent for external review, which took another four months. This journal is really not recommended for submission
(2) 讚! | 尔曹身与名俱灭

作者: 御阪素枝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-14 14:57:23 評論於
Can we have a discussion, although guidance may not be provided? 13805629432
(0) 讚! | 御阪素枝

作者: 飞月谷芹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-14 11:10:09 評論於
Can you please add me on ** and give me some guidance? ?
(0) 讚! | 飞月谷芹

作者: 御阪素枝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-22 16:04:09 評論於
Review speed: 1.0 | Submission hit rate: 50.0 
Research focus: Tuberculosis 
Experience sharing: Today I received the acceptance notice for my first SCI paper, I am especially happy and would like to share my submission process: 
Submitted on December 2, 2021, sent for review on December 5, received first review comments in about two weeks, the expert opinions were pertinent and professional, received major revisions 
Uploaded revised manuscript on January 25, 2022, due to being busy with my master's thesis experiment 
Received second review comments on February 10, 2022, minor revisions requested 
Uploaded revised manuscript on February 19, 2022 
Received acceptance notice on February 24, 2022 
Overall, the review process was very efficient, it would have been even faster if I had not delayed it myself. The experts were very professional, and the editors were very friendly, for those working on tuberculosis, I recommend giving it a try
(0) 讚! | 御阪素枝

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:50:54 評論於
Medicine, Scientific Reports, Plos One, Oncology letter, Oncology report, Cell physiol biochem, Biochemical and biophysical research etc
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 09:39:02 評論於
Is the journal "Water" really not worth choosing? When is it acceptable to submit to "Water"?
(0) 讚! | 八坂篷蔚

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 10:40:20 評論於
Which journals are considered high-impact publications?
(0) 讚! | 修然小公主

作者: Marguerite Black


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-02 21:52:10 評論於
Review speed: 1.0 | Submission hit rate: 25.0
Experience sharing: Submitted on November 27, 2017, quickly entered under review. The review process ended within a month, with two reviewers providing feedback. One reviewer agreed with the structure of the article and provided detailed editing suggestions while pointing out errors. The other reviewer probably didn't read it much, just stating there were many errors and they couldn't understand it. Ultimately, the article was tragically rejected
(0) 讚! | Marguerite Black

作者: 雪梦公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-09 14:10:44 評論於
TB professional magazine. The review process is extremely slow, so it is not recommended to submit articles
(0) 讚! | 雪梦公子

作者: 匿名


領域: 生命科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2013-07-09 10:26:00 評論於
TBProfessional journal.The review is super slow, and I suggest you not select.
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 10:52:39 評論於
It's too unpredictable. It dropped a little more than last year. Can it maintain a 3-point lead next year? I feel it's not reliable
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-04-09 16:38:05 評論於
Review speed: 1.0 Experience Sharing: Submission rejected directly after one week
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-07-25 22:16:16 評論於
The magazine editor is very responsible and will provide detailed explanations for any questions. They are especially friendly to Chinese people and suggest that those specializing in tuberculosis can try submitting articles
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Tuberculosis] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*